At a glance
- Originator Servier
- Class Neuroprotectants
- Mechanism of Action AMPA receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Stroke
Most Recent Events
- 30 Oct 2006 Discontinued - Preclinical for Stroke in France (unspecified route)
- 19 Sep 2002 Preclinical trials in Stroke in France (unspecified route)